Delivery Order SPE2DB22D3016-SPE2DB24FAYY1

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,565,877,751 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 19, 2024 with a ceiling value of $11,523.56. The delivery order contract is firm-fixed price and has an ultimate completion date of September 20, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $17,808.37 for the supply of 4,565,782,805 units of Epinephrine 0.3 mg Auto-Injectors. The contract has an ultimate completion date of September 13, 2024 and was awarded by the Defense Logistics Agency (DLA), a defense agency, on September 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award is for the delivery of 4,566,077,688 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and has been awarded this $3,301.26 contract with a completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $1,547.00, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,837.44 delivery order is for the supply of 4564661917 - EPINEPHRINE 0.3 MG AUTO-INJECT 2S, with a period of performance through May 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of epinephrine 0.3 mg auto-inject devices. The $2,231.90 firm-fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the U.S. Department of Defense. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical devices. The $1,495.30 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 5, 2024 with a completion date of July 8, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
The U.S. Defense Logistics Agency (DLA) awarded a $20,108.46 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the delivery of 4566026543 EPINEPHRINE 0.3 MG AUTO-INJECT 2S, with a completion date of October 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the agency...
The Defense Logistics Agency (DLA) awarded a delivery order worth $2,875.50 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,837,064 units of Epinephrine 0.3 mg auto-injectors. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Epinephrine 0.3 mg auto-injectors to support the U.S. government. The $10,435.73 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support to the military. The contract has an ultimate completion date of October 9, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAYY1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,364.31 for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The contract has an ultimate completion date of June 21, 2024 and was awarded by the Defense Logistics Agency (DLA), a defense agency. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:07 AM